Radboud university medical center. Department Obstetrics & Gynaecology.
Nijmegen, Gelderland, 6500HB, Netherlands
NCT Number: NCT03381300
Rationale: Infertility due is a major concern for girls with Turner syndrome (TS) and their parents. Physicians are often asked about possible options to preserve their fertility. However, despite some experimental case reports, clear evidence for fertility preservation in these girls is lacking and many questions remain. Without evidence on the effectiveness of fertility preservation it cannot routinely be offered to girls with TS.
Objective: To investigate the occurrence of live birth in women with TS after ovarian tissue cryopreservation in childhood followed by auto transplantation in adulthood.
Study design: A national multicentre exploratory intervention study
Study population: Girls diagnosed with Turner Syndrome, aged 2-18 years.
Intervention: Ovarian tissue cryopreservation in childhood followed by auto transplantation in adulthood. In order to obtain the ovarian tissue for cryopreservation, all girls must undergo a laparoscopy under general anaesthesia which will be performed in academic/university clinics with paediatric surgery. During the laparoscopic intervention, a unilateral oophorectomy will be performed, thereby leaving the other ovary intact for hormone production, ovulation, spontaneous pregnancies and as an auto transplantation site for cryopreserved-thawed ovarian cortical tissue later on. Furthermore, a small sample of the ovarian cortex will be used to assess the oocyte quality and genetics (e.g. the presence of germ line mosaicism). Oocytes will be karyotyped by using Fluorescence in situ hybridization (FISH). Karyotypic and hormonal data will be collected once at the yearly clinical visit at the paediatric-endocrinologist. Therefore, a buccal swab and one extra blood sample will be taken and evaluated during the routine laboratory evaluation.
In the future, auto transplantation of frozen-thawed ovarian cortex strips will be performed.
This study is active but is not currently recruiting participants.
Notify Me2 year–18 year
Female
Interventional
Not applicable
Nijmegen, Gelderland, 6500HB, Netherlands
Nature and extent of the burden and risks associated with participation, benefit and group relatedness:
The primary objective remains to preserve the fertility of the respective (minor) patient, facing a very high risk of premature ovarian insufficiency (POI) of 95-98%. Disadvantages of participating in this study are the potential risk of complications related to the laparoscopic unilateral oophorectomy and/or the unknown effect on future fertility of these girls. Moreover, the procedure might raise false hope in patients (and/or parents) about the chance of getting pregnant after auto transplantation of cryopreserved-thawed ovarian tissue in the future. However, we attempt to overcome this by extensive and objective information provision by both written materials and face to face counselling.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
Exclusion criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
Laparoscopic unilateral oophorectomy followed by cryopreservation of ovarian cortex tissue
Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.
Time frame: Within 1 month after ovarian tissue cryopreservation
The number of primordial follicles found in the ovarian tissue
Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.
The association between patient's age at cryopreservation and LBR
Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.
The association between patient's genotype and LBR
Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.
The association between patient's AMH level at cryopreservation and LBR
Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.
The association between patient's FSH level at cryopreservation and LBR
Time frame: Up to 3 years after inclusion
The willingness of girls with TS to perform a unilateral oophorectomy for fertility preservation (i.e. the study participation rate)
Time frame: Up to 3 years after inclusion
The number of eligible participants
Time frame: Up to 3 years after inclusion
The age of the participant
Time frame: Up to 3 years after inclusion
The incidence of somatic mosaicism (i.e. buccal cells versus peripheral lymphocytes)
Time frame: Up to 3 years after inclusion
The incidence of germ cell mosaicism (i.e. ovarian cells versus peripheral lymphocytes and buccal cells)
Time frame: Up to 3 years after inclusion
Serum hormone levels (i.e. FSH, Luteinizing hormone (LH), AMH, E2, inhibin B)
Time frame: Up to 1 year after the laparoscopic procedure
The number of complications related to the laparoscopic procedure
Time frame: Up to 10 years after the laparoscopic procedure
The incidence of puberty and/or menarche after laparoscopic oophorectomy
Time frame: Up to 45 years after the laparoscopic procedure
The incidence of spontaneous pregnancies after laparoscopic oophorectomy
Time frame: Up to 2 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue
The incidence of menstruation cycle recovery after auto transplantation of cryopreserved-thawed ovarian tissue in the future
Time frame: Up to 2 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue
The incidence of pregnancies after auto transplantation of cryopreserved-thawed ovarian tissue in the future
Time frame: Up to 2 years and 3 months after auto transplantation of cryopreserved-thawed ovarian cortical tissue
The incidence of ongoing pregnancies after auto transplantation of cryopreserved-thawed ovarian tissue in the future
Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue
The number of miscarriages after auto transplantation of cryopreserved-thawed ovarian tissue in the future
Time frame: Up to 2 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue
Time to pregnancy after auto transplantation of cryopreserved-thawed ovarian tissue in the future
Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue
Time to live birth after auto transplantation of cryopreserved-thawed ovarian tissue in the future
Radboud University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05885048
Cancer, Effects of Immunotherapy
Bern, Switzerland
View Trial DetailsNCT07701252
Behavior, Digital Health Literacy
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT07642531
Fertility Preservation, Gynecologic Cancers
Istanbul, Zeytinburnu, Turkey (Türkiye)
View Trial DetailsNCT06763926
Fertility Preservation
Sabadell, Barcelona, Spain
View Trial Details